Molecular Analysis of Genetic Markers for Non-Hodgkin Lymphomas.
Molecular Analysis of Genetic Markers for Non-Hodgkin Lymphomas.
Curr Protoc Hum Genet. 2017 Apr 06;93:10.14.1-10.14.29
Authors: Sholl LM, Longtine J, Kuo FC
Abstract
Molecular analysis complements the clinical and histopathologic tools used to diagnose and subclassify hematologic malignancies. The presence of clonal antigen-receptor gene rearrangements can help to confirm the diagnosis of a B or T cell lymphoma and can serve as a fingerprint of that neoplasm to be used in identifying concurrent disease at disparate sites or recurrence at future time points. Certain lymphoid malignancies harbor a characteristic chromosomal translocation, a finding that may have significant implications for an individual's prognosis or response to therapy. The polymerase chain reaction (PCR) is typically used to detect antigen-receptor gene rearrangements as well as specific translocations that can be supplemented by fluorescence in situ hybridization (FISH) and karyotype analysis. © 2017 by John Wiley & Sons, Inc.
PMID: 28384399 [PubMed - in process]
Source: Current Protocols in Human Genetics - Category: Genetics & Stem Cells Tags: Curr Protoc Hum Genet Source Type: research
More News: Cancer & Oncology | Genetics | Hematology | Hodgkin's Disease | Lymphoma | T-cell Lymphoma | Translocation